On May 31, 2011, CMS issued revised guidance for pharmaceutical manufacturers regarding appealing invoiced discount payments under the Medicare Part D Drug Coverage Gap Discount Program. The revised guidance reflects comments received on CMS's April 7, 2011 draft version of the document.